A detailed history of Pictet & Cie (Europe) Sa transactions in Globus Medical Inc stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 5,218 shares of GMED stock, worth $435,285. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,218
Previous 9,504 45.1%
Holding current value
$435,285
Previous $650,000 42.62%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$67.08 - $73.92 $287,504 - $316,821
-4,286 Reduced 45.1%
5,218 $373,000
Q2 2024

Jul 25, 2024

BUY
$49.79 - $68.85 $38,238 - $52,876
768 Added 8.79%
9,504 $650,000
Q1 2024

May 07, 2024

BUY
$51.15 - $56.52 $166,697 - $184,198
3,259 Added 59.5%
8,736 $468,000
Q4 2023

Feb 09, 2024

SELL
$43.79 - $55.14 $9,239 - $11,634
-211 Reduced 3.71%
5,477 $291,000
Q3 2023

Nov 02, 2023

BUY
$49.1 - $62.37 $279,280 - $354,760
5,688 New
5,688 $282,000
Q4 2022

Feb 08, 2023

SELL
$58.4 - $75.53 $92,914 - $120,168
-1,591 Reduced 7.15%
20,668 $0
Q3 2022

Nov 10, 2022

SELL
$55.32 - $67.54 $12,944 - $15,804
-234 Reduced 1.04%
22,259 $1.33 Billion
Q2 2022

Aug 05, 2022

SELL
$53.08 - $81.37 $1.11 Million - $1.7 Million
-20,853 Reduced 48.11%
22,493 $1.26 Million
Q1 2022

May 04, 2022

BUY
$63.68 - $75.54 $2,228 - $2,643
35 Added 0.08%
43,346 $3.2 Million
Q4 2021

Feb 02, 2022

BUY
$62.62 - $79.92 $676,421 - $863,295
10,802 Added 33.23%
43,311 $3.13 Million
Q3 2021

Nov 10, 2021

BUY
$76.41 - $84.06 $1.86 Million - $2.04 Million
24,283 Added 295.2%
32,509 $2.49 Million
Q2 2021

Aug 11, 2021

SELL
$61.85 - $77.53 $4.42 Million - $5.54 Million
-71,433 Reduced 89.67%
8,226 $638,000
Q1 2021

May 10, 2021

BUY
$60.05 - $67.74 $4.78 Million - $5.4 Million
79,659 New
79,659 $4.91 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.43B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.